Novocure Ltd
NASDAQ:NVCR

Watchlist Manager
Novocure Ltd Logo
Novocure Ltd
NASDAQ:NVCR
Watchlist
Price: 16.59 USD 2.53% Market Closed
Market Cap: 1.8B USD
Have any thoughts about
Novocure Ltd?
Write Note

Wall Street
Price Targets

NVCR Price Targets Summary
Novocure Ltd

Wall Street analysts forecast NVCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVCR is 28.56 USD with a low forecast of 18.18 USD and a high forecast of 42 USD.

Lowest
Price Target
18.18 USD
10% Upside
Average
Price Target
28.56 USD
72% Upside
Highest
Price Target
42 USD
153% Upside

NVCR Last Price Targets
Novocure Ltd

The latest public price target was made on Oct 16, 2024 by Emily Bodnar from H.C. Wainwright , who expects NVCR stock to rise by 81% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Emily Bodnar
H.C. Wainwright
30 USD
Upside 81%
2 weeks ago
Oct 16, 2024
H.C. Wainwright Upgrades NovoCure Ltd. (NVCR) to Buy
StreetInsider
Emily Bodnar
H.C. Wainwright
24 USD
Upside 45%
3 months ago
Jul 26, 2024
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright
StreetInsider
Emily Bodnar
H.C. Wainwright
22 USD
Upside 33%
6 months ago
May 3, 2024
NovoCure Ltd. (NVCR) PT Lowered to $22 at H.C. Wainwright
StreetInsider
Vijay Kumar
Evercore ISI
14.5 USD
Downside 13%
6 months ago
May 2, 2024
NovoCure Ltd. (NVCR) PT Lowered to $14.50 at Evercore ISI
StreetInsider
Jason Bednar
Piper Sandler
28 USD
Upside 69%
6 months ago
Apr 10, 2024
NovoCure Ltd. (NVCR) PT Raised to $28 at Piper Sandler
StreetInsider
Larry Biegelsen
Wells Fargo
42 USD
Upside 153%
7 months ago
Apr 3, 2024
NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo
StreetInsider
Unknown Analyst
H.C. Wainwright
24 USD
Upside 45%
7 months ago
Mar 27, 2024
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright following positive METIS data
StreetInsider
Show More Price Targets
Show Less Price Targets
Emily Bodnar
H.C. Wainwright
Price Target 30 USD
Upside/Downside 81%
View Source
Emily Bodnar
H.C. Wainwright
Price Target 24 USD
Upside/Downside 45%
View Source
Emily Bodnar
H.C. Wainwright
Price Target 22 USD
Upside/Downside 33%
View Source
Vijay Kumar
Evercore ISI
Price Target 14.5 USD
Upside/Downside 13%
View Source
Jason Bednar
Piper Sandler
Price Target 28 USD
Upside/Downside 69%
View Source
Larry Biegelsen
Wells Fargo
Price Target 42 USD
Upside/Downside 153%
View Source
Unknown Analyst
H.C. Wainwright
Price Target 24 USD
Upside/Downside 45%
View Source
Show More Price Targets
Show Less Price Targets
Novocure Ltd Competitors:
Price Targets
ITGR
Integer Holdings Corp
11% Upside
SOON
Sonova Holding AG
9% Downside
1302
LifeTech Scientific Corp
61% Upside
AXGN
AxoGen Inc
18% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
33% Upside
ATRC
AtriCure Inc
25% Upside
ECOR
electroCore, Inc.
91% Upside
BSX
Boston Scientific Corp
10% Upside

Revenue
Forecast

Revenue Estimate
Novocure Ltd

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 41%. The projected CAGR for the next 3 years is 11%.

41%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVCR's stock price target?
Price Target
28.56 USD

According to Wall Street analysts, the average 1-year price target for NVCR is 28.56 USD with a low forecast of 18.18 USD and a high forecast of 42 USD.

What is Novocure Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 41%. The projected CAGR for the next 3 years is 11%.

Back to Top